Neyazi, S., Yamazawa, E., Hack, K., Tanaka, S., Nagae, G., Kresbach, C., . . . Schüller, U. (2024). Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation. Acta neuropathologica, 147(1), . https://doi.org/10.1007/s00401-023-02668-9
Chicago-Zitierstil (17. Ausg.)Neyazi, Sina, et al. "Transcriptomic and Epigenetic Dissection of Spinal Ependymoma (SP-EPN) Identifies Clinically Relevant Subtypes Enriched for Tumors with and Without NF2 Mutation." Acta Neuropathologica 147, no. 1 (2024). https://doi.org/10.1007/s00401-023-02668-9.
MLA-Zitierstil (9. Ausg.)Neyazi, Sina, et al. "Transcriptomic and Epigenetic Dissection of Spinal Ependymoma (SP-EPN) Identifies Clinically Relevant Subtypes Enriched for Tumors with and Without NF2 Mutation." Acta Neuropathologica, vol. 147, no. 1, 2024, https://doi.org/10.1007/s00401-023-02668-9.